SCHEMBL3854926

SCHEMBL3854926

COC1=CC(=Nc2c(C)n(C)n(-c3ccccc3)c2=O)C=CC1=O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.76
▸ MAPK1 P28482 5/20 0.76
▸ KDM4E B2RXH2 4/20 0.76
▸ MEN1 O00255 4/20 0.76
▸ KMT2A Q03164 4/20 0.76
▸ THRB P10828 2/20 0.76
▸ ATM Q13315 1/20 0.76
▸ ALDH1A1 P00352 11/20 0.67
▸ GAA P10253 10/20 0.67
▸ MPI P34949 3/20 0.67
▸ BLM P54132 1/20 0.67
▸ HTT P42858 4/20 0.62
▸ LMNA P02545 2/20 0.62
▸ POLB P06746 3/20 0.60
▸ TDP1 Q9NUW8 2/20 0.60
▸ G6PD P11413 1/20 0.60
▸ RECQL P46063 1/20 0.60
▸ MITF O75030 1/20 0.59
▸ NSD2 O96028 1/20 0.59
▸ OPRK1 P41145 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3861573 1.00 MAPT (0.76) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL3854924 1.00 MAPT (0.76) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL3854531 0.86 MAPT (1.00) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL3854527 0.86 MAPT (1.00) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL13680051 0.86 MAPT (1.00) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL13680312 0.84 MAPT (0.78) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL20122064 0.84 MAPT (0.78) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL3856367 0.84 MAPT (0.78) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL3856369 0.84 MAPT (0.78) MAPTMAPK1KDM4EMEN1KMT2A
SCHEMBL3864724 0.81 ALDH1A1 (1.00) MAPTMAPK1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
EP-2011787-A1 Dying composition comprising an azomethin-type compound with a pyrazolinone moiety L'Oreal (FR) 2009-01-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit KRT18, KMO, TMPO MAPT 308/4885MAPK1 814/4885KDM4E 1705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback